| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.3 | 0.1 | 1.6 | 6.9 | 2.1 | 1.1 | 0.9 | −15.5% | |
| Selling, general & administrative | 0.5 | 1.0 | 2.1 | 2.5 | 2.1 | 2.2 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 0.8 | 1.1 | 3.7 | 9.4 | 4.2 | 3.2 | 3.1 | −5.4% | |
| Operating income | (0.8) | (1.1) | (3.7) | (9.4) | (4.2) | (3.2) | (3.1) | +5.4% | |
| Interest expense | 1.0 | 0.8 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | — | — | |
| Other income / expense | (1.0) | (0.5) | 2.2 | 0.5 | 0.1 | 0.1 | — | — | |
| Pre-tax income | (1.8) | (1.6) | (1.5) | (8.9) | (4.1) | (3.1) | (2.9) | +7.0% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (1.8) | (1.6) | (1.5) | (8.9) | (4.1) | (3.1) | (2.9) | +7.0% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (35.68) | (37.35) | (31.15) | (34.01) | (4.83) | (2.65) | (1.61) | +39.2% | |
| EPS, diluted (per share) | (35.68) | (37.35) | (31.20) | (34.01) | (4.83) | (2.65) | (1.61) | +39.2% | |
| EBITDA | (0.8) | (0.8) | (0.8) | 0.5 | 0.1 | (3.1) | (3.0) | +2.8% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 9.4 | 4.2 | 0.0 | — | — | |
| Weighted average shares (shares) | 51,000 | 43,000 | 47,596 | 263,137 | 1,517,000 | 1,174,869 | — | — | |
| Weighted average diluted shares (shares) | 51,138 | 43,127 | 47,658 | 263,137 | 1,517,000 | 1,174,869 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
